Navigation Links
Qualcraft™ VestSkirt Apron, Standard

ProductsQualcraft™ VestSkirt Apron, Standard
Company AliMed, Inc.
Item Qualcraft™ VestSkirt Apron, Standard
Features 
  • More comfortable: divides weight between shoulders and hips, reducing fatigue during long-term wear.
  • Vest and Skirt generoulsy overlap in front for double protection.
  • Vest front, 1.0 mm Pb equivalent with overlap (0.5 mm each flap); vest back, 0.25 mm Pb equivalent; skirt front, 0.5 mm Pb equivalent with overlap (0.25 mm each flap and skirt back).
  • Easy open and close Velcro®-type fasteners
  • Skirt includes two 6" x 1" hanging loops and a pocket on the right side.
  • Freedom of movement: plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between the shoulders and hips.
    • Description Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between the shoulders and hips.
    Info AliMed, Inc.
    Customer Service: (800) 225-2610
    Web site: http://www.alimed.com/

    Related medicine products :

    1. Qualcraft™ Belted Coat Apron, Standard
    2. Qualcraft™ Back-Aid Apron
    3. Qualcraft™ Lightweight Tie Apron
    4. Qualcraft™ Lightweight VestSkirt Apron
    5. Qualcraft™ Belted Coat Apron, Lightweight
    6. Qualcraft™ Standard Tie Apron
    7. Qualcraft™ Lead-Free Back-Aid Radiation Protection Apron
    8. Apron,special Procedure
    9. LM-101 Standard Lensmeter
    10. LM-201 Standard Lensmeter
    11. Standard Snellen Chart
    ...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
    ...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
    ...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
    ...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
    Medicine Products:
    (Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
    (Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
    (Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
    (Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
    Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
    ... much dreaded bird flu has been reported from a ch...nxi. The situation is being closely // monitored a...ealth officials from the Agricultural department. ...(Yijing township), confirmed to harbor the H5N1 bi...
    ...o suffer from the Ischemic Heart Disease (IHD) whi...vary from // person to person, depending upon whe... heart is affected by this medical condition, and ... this is quite a common ailment. When patients s...
    ... in the February issue of the Journal of Periodont...s raise the risk of developing preeclampsia in pre...that preeclamptic mothers have low birth weight ba...ve preeclampsia. "We found that chronic periodonti...
    ... led by Jeong Won Jang of the Department of Intern... Seoul, has found // that administering an antiv...n patients who are undergoing chemotherapy for the... carcinoma (HCC), patients have a 55 percent chanc...
    Other Medicine News:Health News:Gum Disease Associated With Increased Risk of Preeclampsia 2Health News:Hepatitis B Relapse In Cancer Chemotherapy Can Be Avoided By Antiviral Drug 2
    (Date:9/5/2008)...t. 5 /- When Michigan,s first chronic... deer at a deer farm in,Kent County, state and fed...on the farmer,s property and began the process of ...suing the following statement on the negative CWD,...ounty Farm., The deer farm industry today receive...
    (Date:9/5/2008)...Sept. 5 /PRNewswire-USNewswire/ -- Cancer patients...own as chemobrain. Now in,animal studies at West V...at injections of N-acetyl cysteine (NAC), an antio...ncer chemotherapy drugs sometimes induce., In the...r issue of the,journal Metabolic Brain Disease, ra...
    (Date:9/5/2008)..., Calif., Sept. 5 /- SARcod...molecule LFA-1 inhibitors,to treat inflammatory di...,SNSS) today announced SARcode,s initiation of a P...oduct candidate for T-cell mediated ophthalmic,dis...agreement providing,SARcode with an exclusive lice...
    (Date:9/5/2008)...s microRNAs Extracted From a Simple Blood Draw Hav...markers for a Wide Range of ...gy, Rosetta Genomics is Currently Developing ..., REHOVOT, Israel and JERSEY CITY, New Jersey, Se...cs, Ltd. (NASDQ: ROSG), a leader in,the developmen...
    Breaking Medicine Technology:Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 2Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 3Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4Natural Nutrition Announces Effectiveness of Forward Split of Common Stock Following 2007 Record Revenue Year 12001 1Natural Nutrition Announces Effectiveness of Forward Split of Common Stock Following 2007 Record Revenue Year 12001 2Transplanted Liver Lining Cells May Cure Hemophilia 11999 1Transplanted Liver Lining Cells May Cure Hemophilia 11999 2Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 11997 1Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 11997 2Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 11997 3Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 11997 4Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 11997 5Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 11997 6ADA Calls for All Stakeholders to Work Together to Help Medicaid 11995 1ADA Calls for All Stakeholders to Work Together to Help Medicaid 11995 2
    ... Trial Presented at EULAR, BARCELONA, Spain, June ...today at the European League Against Rheumatism (E...wed that patients with,ankylosing spondylitis (AS)...ars experienced significant improvement in spinal,...howed sustained,reductions in spinal inflammation ...
    ...in Cancer Research, TARRYTOWN, N.Y., June 15, 2007...ay announced the results of scientific studies tha...ective in treating,multiple types of human tumors ...MPC-6827 exerts its effects, and (3) show that,MPC...o be involved,in cancer drug resistance. The study...
    Other Medicine Technology:Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 2Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 3Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 4Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 5Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 6Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 7Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 8Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 9Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 10Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 11Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 12New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 2New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 3New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 4New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 6